Case Report
BibTex RIS Cite

Report of Familial Mediterranean Fever with Repeating Localized Rash and Weakness

Year 2020, Volume: 4 Issue: 1, 34 - 37, 30.04.2020

Coşkun Ekemen Ahmet Girgeç Hakan Kardeş Zühal Örnek

Abstract

Familial Mediterranean Fever (FMF), which is inherited as autosomal recessive, is characterized
by recurrent fever, rash, arthritis, arthralgia, and abdominal pain. The most important complication
of FMF, which can affect many systems, is amyloidosis development due to kidney involvement.
The main drug used in the treatment is colchicine. In this article, a case which arrived at the
pediatric clinic with recurrent unilateral localized ankle complaints of edema, erythema together
with rash and which, as a result of clinical and genetic tests, was diagnosed as FMF is examined.
Symptoms observed at the preliminary diagnosis such as recurrent fever, abdominal pain, arthritis
or arthralgia or isolated erysipelas should definitely remind pediatricians FMF. In this way, early
amyloidosis development and complications due to FMF will be prevented in children

Keywords

FMF Familial Mediterranean Fever Arthritis Rash

References

  • 1. Önen F. Ailevi Akdeniz ateşi. Rheumatol Int. 2006; 26 : 489–96
  • 2. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972;287:1302.
  • 3. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53
  • 4. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
  • 5. Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009;61:1447–53.
  • 6. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine(Baltimore) 1998;77(4):268–97.
  • 7. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005;84:1–11.
  • 8. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416–9.
  • 9. Jarjour RA, Dodaki R. Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep. 2011;38:2033–6.
  • 10. Ince E, Cakar N, Tekin M, Kendirli T, Ozkaya N, Akar N, et al. Arthritis in children with familial Mediterranean fever. Rheumatol Int. 2002;21:213–7.
  • 11. Üzüm Ö ve ark., Familial Mediterranean fever and prolonged febrile myalgia syndrome: Case report, İzmir Dr. Behçet Uz Çocuk Hast. Dergisi 2017; 7(2):164-166
  • 12. Ceylan Ö, Ceylan Y. Intermittent right bundle branch block in a child with familial mediterranean fever. Cardiol J. 2018;25(6):753-755.
  • 13. Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopatho logic correlation. J Am Acad Dermatol. 2000;42:791–5.
  • 14. Petty RE, Cassidy JT. Textbook of pediatric rheumatology.Philadelphia: Saunders Elsevier; 2011
  • 15. Lidar M, Doron A, Barzilai A, vd. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever J Eur Acad DermatolVenereol 2013; 27: 912.
  • 16. Keskindemirci G ve ark. Çocuklarda Lenfadenopatinin Nadir Bir Nedeni: Otoinflamatuvar Hastalık - Ailevi Akdeniz Ateşi, Turkish J Pediatr Dis ,2016; 4: 274-276
  • 17. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol. 1998;27:92–7.
  • 18. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974;291:934–7.
  • 19. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med.1974;291:9324.
  • 20. Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med. 1974;81:792–4.
  • 21. Erken E, Ozer HT, Bozkurt B, Gunesacar R, Erken EG, Dinkci S. Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion. Joint Bone Spine. 2008;75:370–2.
  • 22. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum. 2011;41:265–71.

Tekrarlayan Lokalize Döküntü ve Halsizlikle Başvuran Ailesel Akdeniz Ateşi Olgu Sunumu

Year 2020, Volume: 4 Issue: 1, 34 - 37, 30.04.2020

Coşkun Ekemen Ahmet Girgeç Hakan Kardeş Zühal Örnek

Abstract

Otozomal resesif kalıtılan Ailesel Akdeniz Ateşi tekrarlayan ateş, döküntü, artrit, artralji, karın ağrısı
gibi klinik bulgularla karakterizedir. Birçok sistemi tutabilen FMF’nin en önemli komplikasyonu
böbrek tutulumuna bağlı amiloidoz gelişimidir. Tedavide kullanılan temel ilaç ise kolşisindir. Bu
makalede çocuk hastalıkları polikliniğine tekrarlayan tek taraflı lokalize ayak bileğinde ödem, kızarıklık
ve döküntü yakınmaları ile başvuran ve takibinde klinik ve genetik tetkikler sonucunda
FMF tanısı alan bir olgu sunulmuştur. Tekrarlayan ateş, karın ağrısı, artrit veya artralji ya da izole
erizipel benzeri döküntüsü olan çocuklarda FMF ön tanıda mutlaka akla gelmelidir. Bu sayede
çocuklarda erken amiloidoz gelişimi ve FMF’e bağlı komplikasyonlar da engellenmiş olacaktır

Keywords

FMF ailesel akdeniz ateşi artrit döküntü

References

  • 1. Önen F. Ailevi Akdeniz ateşi. Rheumatol Int. 2006; 26 : 489–96
  • 2. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972;287:1302.
  • 3. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53
  • 4. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
  • 5. Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009;61:1447–53.
  • 6. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine(Baltimore) 1998;77(4):268–97.
  • 7. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005;84:1–11.
  • 8. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416–9.
  • 9. Jarjour RA, Dodaki R. Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep. 2011;38:2033–6.
  • 10. Ince E, Cakar N, Tekin M, Kendirli T, Ozkaya N, Akar N, et al. Arthritis in children with familial Mediterranean fever. Rheumatol Int. 2002;21:213–7.
  • 11. Üzüm Ö ve ark., Familial Mediterranean fever and prolonged febrile myalgia syndrome: Case report, İzmir Dr. Behçet Uz Çocuk Hast. Dergisi 2017; 7(2):164-166
  • 12. Ceylan Ö, Ceylan Y. Intermittent right bundle branch block in a child with familial mediterranean fever. Cardiol J. 2018;25(6):753-755.
  • 13. Barzilai A, Langevitz P, Goldberg I, Kopolovic J, Livneh A, Pras M, et al. Erysipelas-like erythema of familial Mediterranean fever: clinicopatho logic correlation. J Am Acad Dermatol. 2000;42:791–5.
  • 14. Petty RE, Cassidy JT. Textbook of pediatric rheumatology.Philadelphia: Saunders Elsevier; 2011
  • 15. Lidar M, Doron A, Barzilai A, vd. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever J Eur Acad DermatolVenereol 2013; 27: 912.
  • 16. Keskindemirci G ve ark. Çocuklarda Lenfadenopatinin Nadir Bir Nedeni: Otoinflamatuvar Hastalık - Ailevi Akdeniz Ateşi, Turkish J Pediatr Dis ,2016; 4: 274-276
  • 17. Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol. 1998;27:92–7.
  • 18. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974;291:934–7.
  • 19. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med.1974;291:9324.
  • 20. Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med. 1974;81:792–4.
  • 21. Erken E, Ozer HT, Bozkurt B, Gunesacar R, Erken EG, Dinkci S. Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion. Joint Bone Spine. 2008;75:370–2.
  • 22. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum. 2011;41:265–71.
There are 22 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

Coşkun Ekemen 0000-0002-1957-9855

Ahmet Girgeç 0000-0002-0373-9615

Hakan Kardeş 0000-0002-0553-7072

Zühal Örnek 0000-0001-9252-1652

Publication Date April 30, 2020
Acceptance Date April 29, 2020
Published in Issue Year 2020 Volume: 4 Issue: 1

Cite

Vancouver Ekemen C, Girgeç A, Kardeş H, Örnek Z. Tekrarlayan Lokalize Döküntü ve Halsizlikle Başvuran Ailesel Akdeniz Ateşi Olgu Sunumu. Med J West Black Sea. 2020;4(1):34-7.
 Download Cover Image

Medical Journal of Western Black Sea is a scientific publication of Zonguldak Bulent Ecevit University Faculty of Medicine.

This is a refereed journal, which aims at achieving free knowledge to the national and international organizations and individuals related to medical sciences in publishedand electronic forms.

This journal is published three annually in April, August and December.
The publication language of the journal is Turkish and English.